Displaying 1–19 of 19 results for Tefen

Sort By Relevance Sort By Date

Is Pharma Stuck on the Way to Six Sigma?

(Article)

Six Sigma and OpEx now take a back seat to cost-cutting, yet experts say cost reduction will, ultimately, drive the industry’s transformation

From the Editor: Can Healthcare Reform Cure a Risk-Averse Pharma?

(Article)

Pressures to boost output, with lower short-term profits, will drive name-brand and generic companies to new technologies, and tools such as PAT. Or will they?

Building a New Tech Transfer Model

(Article)

As blockbuster and generic business models merge, tech transfer must change.

Part 1: State of the Industry: A Tefen Series: Operational Excellence in the ...

(Whitepaper)

The life sciences industry is under pressure from the decline in the discovery of block-buster products, aggressive strategies from the generic manufacturers, the emergence of competitors from the East, and the global economic downturn. These factors are causing the pharmaceutical, biotech, and ...

Part 3: Learning from the Industry: A Tefen Series: Operational Excellence in...

(Whitepaper)

Tefen Ltd conducted a study in 2008 & 2009 on 11 life sciences companies, including AstraZeneca, Bayer Schering, GSK Bio, Ipsen, Janssen, Merck Serono, Novartis, Nycomed, Schering Plough, and Wyeth. The research focused on their Operational Excellence (OpEx) programs and is discussed in this ...

Part 2: Operational Excellence Programs in the Industry: A Tefen Series: OpEx...

(Whitepaper)

Tefen Ltd. conducted a study in 2008-2009 on 11 life sciences companies, including AstraZeneca, Bayer Schering, GSK Bio, Ipsen, Janssen, Merck Serono, Novartis, Nycomed, Schering Plough, and Wyeth. The research focused on their Operational Excellence (OpEx) programs and is discusses in this three...

Flexible Pharma: Puzzling Out the Plant of the Future

(Article)

The need to improve agility and reduce financial risk is driving new approaches to plant design and operation, and the use of new technologies. Industry experts look at the future pharmaceutical plant from all angles.

From the Editor: Visiting Toyota

(Article)

The automaker is now entering a mature, more challenging phase of its history, yet has managed to keep its core principles intact. are there lessons here for pharma?

Visiting Toyota

(Article)

The automaker is now entering a mature, more challenging phase of its history, yet has managed to keep its core principles intact. Are there lessons here for pharma?

Lean Pharma: If Only It Were This Easy

(Article)

Our latest operational excellence survey suggests that tools aren't always aligned with goals, and that more management support is needed.

Pathway to Continuous Improvement

(Article)

Operational excellence requires a deep commitment and a culture of change. A recent survey shows where pharmaceutical manufacturers stand on the path.

ESA Biosciences Knowledge Center

ESA Biosciences provides novel products and services with an understanding of the scientific needs of customers and 40-year expertise in small molecule and biomolecule detection. We design and manufacture specialty HPLC detectors, including the Corona charged aerosol detector and Coulochem III ...

Sort By Relevance Sort By Date